Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Tight control of blood glucose is the most important strategy for the treatment of diabetes mellitus. Here, we investigated the beneficial effects of Welsh onion on fasting and postprandial hyperglycemia. Inhibitory activities of hot water extracts from the green stalk and white bulb, which are the edible portions of the Welsh onion, and the fibrous root extract against yeast α-glucosidase were measured in vitro. To study the effects of Welsh onion on postprandial hyperglycemia, a starch solution (1 g/kg) with and without Welsh onion fibrous root extract (500 mg/kg) or acarbose (50 mg/kg) was administered to streptozotocin-induced diabetic rats after an overnight fast. Postprandial plasma glucose levels were measured and incremental areas under the response curve were calculated. To study the hypoglycemic effects of chronic feeding of Welsh onion, five-week-old db/db mice were fed an AIN-93G diet or a diet containing either Welsh onion fibrous root extract at 0.5% or acarbose at 0.05% for 7 weeks after 1 week of adaptation. Fasting plasma glucose and blood glycated hemoglobin were measured. Compared to the extract from the edible portions of Welsh onion, the fibrous root extract showed stronger inhibition against yeast α-glucosidase, with an IC50 of 239 μg/mL. Oral administration of Welsh onion fibrous root extract (500 mg/kg) and acarbose (50 mg/kg) significantly decreased incremental plasma glucose levels 30-120 min after oral ingestion of starch as well as the area under the postprandial glucose response curve, compared to the control group (P < 0.01). The plasma glucose and blood glycated hemoglobin levels of the Welsh onion group were significantly lower than those of the control group (P <0.01), and were not significantly different from those fed acarbose. Thus, we conclude that the fibrous root of Welsh onion is effective in controlling hyperglycemia in animal models of diabetes mellitus.
Abstract
Tight control of blood glucose is the most important strategy for the treatment of diabetes mellitus. Here, we investigated the beneficial effects of Welsh onion on fasting and postprandial hyperglycemia. Inhibitory activities of hot water extracts from the green stalk and white bulb, which are the edible portions of the Welsh onion, and the fibrous root extract against yeast α-glucosidase were measured in vitro. To study the effects of Welsh onion on postprandial hyperglycemia, a starch solution (1 g/kg) with and without Welsh onion fibrous root extract (500 mg/kg) or acarbose (50 mg/kg) was administered to streptozotocin-induced diabetic rats after an overnight fast. Postprandial plasma glucose levels were measured and incremental areas under the response curve were calculated. To study the hypoglycemic effects of chronic feeding of Welsh onion, five-week-old db/db mice were fed an AIN-93G diet or a diet containing either Welsh onion fibrous root extract at 0.5% or acarbose at 0.05% for 7 weeks after 1 week of adaptation. Fasting plasma glucose and blood glycated hemoglobin were measured. Compared to the extract from the edible portions of Welsh onion, the fibrous root extract showed stronger inhibition against yeast α-glucosidase, with an IC50 of 239 μg/mL. Oral administration of Welsh onion fibrous root extract (500 mg/kg) and acarbose (50 mg/kg) significantly decreased incremental plasma glucose levels 30-120 min after oral ingestion of starch as well as the area under the postprandial glucose response curve, compared to the control group (P < 0.01). The plasma glucose and blood glycated hemoglobin levels of the Welsh onion group were significantly lower than those of the control group (P <0.01), and were not significantly different from those fed acarbose. Thus, we conclude that the fibrous root of Welsh onion is effective in controlling hyperglycemia in animal models of diabetes mellitus.
참고문헌 (38)
- King H, "Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections", Diabetes Care, 21, pp.1414~1431 (1998)
- American Diabetes Association (ADA), "Summary of revisions for the 2008 clinical practice recommendations", Diabetes Care, 31, pp.S3~S4 (2008)
- UK Prospective Diabetes Study (UKPDS) Group, "Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)", Lancet, 352, pp.837~853 (1998)
- Abrahamson MJ, "Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context", Arch Intern Med, 164, pp.486~491 (2004)
- Standl E, "Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy", Diabetes Obes Metab, 1, pp.215~220 (1999)
- Sels JP, "Miglitol, a new alpha-glucosidase inhibitor", Expert Opin Pharmacother, 1, pp.149~156 (1999)
- Fujita H, "Fermented soybean-derived water-soluble Touchi extract inhibits alpha-glucosidase and is antiglycemic in rats and humans after single oral treatments", J Nutr, 131, pp.1211~1213 (2001)
- Shim YJ, "Inhibitory effect of aqueous extract from the gall of Rhus Chinensis on alpha-glucosidase activity and postprandial blood glucose", J Ethnopharmacol, 85, pp.283~287 (2003)
- Gholamhoseinian A, "Inhibitory effect of methanol extract of Rosa damascena Mill. flowers on alphaglucosidase activity and postprandial hyperglycemia in normal and diabetic rats", Phytomedicine, 16, pp.935~941 (2009)
- Hee-Jeong Joo, "The Hypoglycemic Effect of Saururus chinensis Baill in Animal Modelsof Diabetes Mellitus", Food Science and Biotechnology, 15(3), pp.413~417 (2006), 한국식품과학회
- Wang H, "α-Glucosidase and α-amylase inhibitory activities of guava leaves", Food Chem, 123, pp.6~13 (2010)
- Yamamoto Y, "Antioxidative and antihypertensive effects of Welsh onion on rats fed with a high-fat high-sucrose diet", Biosci Biotechnol Biochem, 69, pp.1311~1317 (2005)
- Yamamoto Y, "Welsh onion attenuates hyperlipidemia in rats fed on high-fat high-sucrose diet", Biosci Biotechnol Biochem, 74, pp.402~404 (2010)
- Yoshino G, "Dyslipidemia in diabetes mellitus", Diabetes Res Clin Pract, 33, pp.1~14 (1996)
- Maritim AC, "Diabetes, oxidative stress, and antioxidants: a review", J Biochem Mol Toxicol, 17, pp.24~38 (2003)
- Kaneto H, "Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance", Int J Biochem Cell Biol, 37, pp.1595~1608 (2005)
- Youn JY, "Anti-hypergltcemic activity of Commelina communis L.: inhibition of α-glucosidase", Diabetes Res Clin Pract, 66, pp.S149~S155 (2004)
- Watanabe J, "Isolation and identification of α-glucosidase inhibitors from Tochu-cha", Biosci Biotechnol Biochem, 61, pp.177~178 (1997)
- Akbarzadeh A, "Induction of diabetes by streptozotocin in rats", Indian J Clin Biochem, 22, pp.60~64 (2007)
- 김정인, "Inhibitory activity of Euonymus alatus against alpha-glucosidase in vitro and in vivo", Nutrition Research and Practice, 1(3), pp.184~188 (2007), 한국영양학회
- Raabo E, "On the enzymatic determination of blood glucose", Scand J Clin Lab Invest, 12, pp.402~407 (1960)
- Reeves PG, "AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet", J Nutr, 123, pp.1939~1951 (1993)
- Schifreen RS, "Accuracy, precision, and stability in measurement of hemoglobin A1c by “high performance” cation-exchange chromatography", Clin Chem, 26, pp.466~472 (1980)
- Hanefeld M, "The role of acarbose in the treatment of non-insulindependent diabetes mellitus", J Diabetes Complications, 12, pp.228~237 (1998)
- "Functional Food"[URL]
- Saito M, "Role of FOSHU (food for specified health uses) for healthier life", Yakugaku Zasshi, 127, pp.407~416 (2007)
- Haller H, "The clinical importance of postprandial glucose", Diabetes Res Clin Pract, 40, pp.S43~S49 (1998)
- Ceriello A, "Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update", Nutr Metab Cardiovasc Dis, 16, pp.453~456 (2006)
- Holman RR, "A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)", Diabetes Care, 22, pp.960~964 (1999)
- Balflour JA, "An update of its pharmacology and therapeutic use in diabetes mellitus", Drugs, 46, pp.1025~1054 (1993)
- Coniff RF, "Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study", Diabetes Care, 18, pp.817~824 (1995)
- Meneilly GS, "Effect of acarbose on insulin sensitivity in elderly patients with diabetes", Diabetes Care, 23, pp.1162~1167 (2000)
- Lebovitz HE, "α-Glucosidase inhibitors as agents in the treatment of diabetes", Diabetes Rev, 6, pp.132~145 (1998)
- Dolan PL, "Effects of feeding acarbose on muscle glucose transport and GLUT4 protein in lean and obese diabetic (ZDFIGmi-fa) rats", J Nutr Biochem, 8, pp.322~327 (1997)
- Sacks DB, "Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus", Clin Chem, 48, pp.436~472 (2002)
- LeRoith D, "Monitoring glycemic control: the cornerstone of diabetes care", Clin Ther, 27, pp.1489~1499 (2005)
- Knowler WC, "Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", N Engl J Med, 346, pp.393~403 (2002)
- Stratton IM, "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study", BMJ, 321, pp.405~412 (2000)